Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-20 Sale(A) | 2023-11-28 4:00 pm | T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer | 537 | $0.65 | $349 | 5,716 (Direct) | View |
| 2023-09-27 Sale | 2023-09-29 4:30 pm | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner | 13,130,147 | $0.17303 | $2,271,957 | 0 (Indirect) | View |
| 2023-09-26 Sale | 2023-09-28 4:30 pm | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner | 5,392,920 | $0.2007 | $1,082,359 | 3,559,165 (Indirect) | View |
| 2023-09-25 Sale | 2023-09-27 5:53 pm | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner | 250,000 | $0.25 | $62,500 | 5,021,014 (Indirect) | View |
| 2023-09-22 Sale | 2023-09-26 5:15 pm | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner | 5,079,344 | $0.2588 | $1,314,534 | 5,088,781 (Indirect) | View |
| 2023-09-21 Sale | 2023-09-25 8:30 pm | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner | 6,338,211 | $0.3005 | $1,904,632 | 6,465,629 (Indirect) | View |
| 2023-09-20 Sale | 2023-09-22 4:15 pm | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner | 7,753,710 | $0.3106 | $2,408,302 | 8,183,716 (Indirect) | View |
| 2023-09-19 Sale | 2023-09-21 4:30 pm | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner | 10,401,466 | $0.366 | $3,806,937 | 10,285,500 (Indirect) | View |
| 2023-03-28 Sale | 2023-04-06 1:08 pm | T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel | 239 | $0.481 | $115 | 6,612 (Direct) | View |
| 2023-02-22 Sale | 2023-03-09 4:00 pm | T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer | 537 | $0.65 | $349 | 3,508 (Direct) | View |
| 2023-02-22 Sale | 2023-03-09 4:00 pm | T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer | 2,693 | $0.62442 | $1,682 | 18,182 (Direct) | View |
| 2023-02-22 Sale | 2023-03-09 4:00 pm | T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel | 3,730 | $0.6245 | $2,329 | 17,431 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-12 Option Award | 2024-04-16 8:35 pm | 2024-04-12 N/A | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III (Cayman) Lev AIV I L.P. CRG Partners III - Parallel Fund B (Cayman) L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. 10% Owner | 3,297,778 | $0 | 906,451 (Indirect) | View |
| 2024-02-24 Exercise | 2024-02-27 4:31 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Sperzel John J III See Remarks | 67 | $0 | 400 (Direct) | View |
| 2024-02-24 Exercise | 2024-02-27 4:30 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer | 29 | $0 | 141 (Direct) | View |
| 2024-02-24 Exercise | 2024-02-27 4:30 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel | 29 | $0 | 135 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-20 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel | 40 | $0 | 146 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-20 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer | 40 | $0 | 152 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-20 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer | 40 | $0 | 152 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-20 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Sperzel John J III See Remarks | 160 | $0 | 493 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-20 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer | 13 | $0 | 90 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-20 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer | 13 | $0 | 90 (Direct) | View |
| 2024-02-14 Conversion | 2024-02-16 5:17 pm | 2023-07-03 N/A | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III (Cayman) Lev AIV I L.P. CRG Partners III - Parallel Fund B (Cayman) L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. 10% Owner | 906,642 | $0 | 499,148 (Indirect) | View |
| 2024-01-01 Option Award | 2024-01-03 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Toft Robin Director | 6,369 | $0 | 6,369 (Direct) | View |
| 2023-11-08 Exercise | 2023-11-28 4:05 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer | 33 | $0 | 98 (Direct) | View |
| 2023-02-20 Exercise(A) | 2023-11-28 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer | 1,333 | $0 | 5,716 (Direct) | View |
| 2023-10-18 Exercise | 2023-10-20 4:16 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Adams Laura Lee Director | 7 | $0 | 44 (Direct) | View |
| 2023-09-15 Exercise | 2023-10-11 5:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Elsbree David B Director | 2,300 | $0 | 8,024 (Direct) | View |
| 2023-09-15 Exercise | 2023-10-11 5:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Toft Robin Director | 2,300 | $0 | 5,772 (Direct) | View |
| 2023-09-15 Exercise | 2023-10-11 5:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | CUMMING JOHN W Director | 2,600 | $0 | 5,256 (Direct) | View |
| 2023-09-15 Exercise | 2023-10-11 5:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Saunders Ninfa Director | 2,300 | $0 | 7,322 (Direct) | View |
| 2023-09-15 Exercise | 2023-10-11 5:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Adams Laura Lee Director | 2,300 | $0 | 3,032 (Direct) | View |
| 2023-09-15 Exercise | 2023-10-11 5:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | LIEBMAN SEYMOUR Director | 2,300 | $0 | 7,002 (Direct) | View |
| 2023-09-15 Exercise | 2023-10-11 5:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Bernard Thierry Director | 2,300 | $0 | 7,322 (Direct) | View |
| 2023-01-01 Exercise | 2023-08-16 4:01 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Bernard Thierry Director | 2,004 | $0 | 5,022 (Direct) | View |
| 2023-01-01 Exercise | 2023-08-16 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Saunders Ninfa Director | 2,004 | $0 | 5,022 (Direct) | View |
| 2023-08-06 Exercise | 2023-08-16 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Toft Robin Director | 454 | $0 | 3,472 (Direct) | View |
| 2023-07-03 Option Award(A) | 2023-07-14 6:57 pm | N/A N/A | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. CRG Partners III - Parallel Fund B (Cayman) L.P. 10% Owner | 93,298 | $0 | 93,298 (Indirect) | View |
| 2023-07-03 Option Award | 2023-07-06 6:44 pm | N/A N/A | T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner | 48,345,798 | $0 | 13,105,006 (Indirect) | View |
| 2023-03-24 Exercise(A) | 2023-04-05 2:30 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel | 334 | $0 | 6,851 (Direct) | View |
| 2023-03-24 Exercise | 2023-03-28 4:02 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel | 333 | $0 | 6,850 (Direct) | View |
| 2022-10-18 Exercise | 2023-03-09 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Adams Laura Lee Director | 732 | $0 | 2,196 (Direct) | View |
| 2023-02-20 Exercise | 2023-03-09 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer | 1,333 | $0 | 3,508 (Direct) | View |
| 2023-02-20 Exercise | 2023-03-09 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer | 6,914 | $0 | 18,182 (Direct) | View |
| 2023-02-20 Exercise | 2023-03-09 4:00 pm | N/A N/A | T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel | 6,914 | $0 | 17,431 (Direct) | View |